New Take on a Prostate Drug, and a New Debate

from the New York Times (Registration Required)

For the first time, leading prostate cancer specialists say, they have a drug that can significantly cut men's risk of developing the disease, dropping the incidence by 30 percent.

But the discovery, arising from a new analysis of a large federal study, comes with a debate: Should men take the drug?

Prostate cancer is unlike any other because it is relatively slow-growing, and while it can kill, it often is not lethal. In fact, most leading specialists say, a major problem is that men are getting screened, discovering they have cancers that may or may not be dangerous, and opting for treatments that can leave them impotent or incontinent.

Science in the Media

Newspapers:

Magazines and Web Sites:

The Science-Media Intersection:

Science Blogs

Sign Up

... for Sigma Xi SmartBrief, a free daily summary of the latest news in scientific research, delivered straight to your in-box. Each story is summarized concisely and linked directly to the original source for further reading.

Click here to subscribe.

Subscribe to Our Content!

Visit our RSS Feeds page to choose among 13 customized feeds, or create a free My AmSci account to request an email notice whenever a specified author, department or discipline appears online.

EMAIL TO A FRIEND :

Of Possible Interest

Profile: Behind the Scenes of Foldit, Pioneering Science Gamification

Science In The News Daily: Three Doctors Charged in Armstrong Doping Case

Science In The News Daily: EPA Issues New Soot Regulations